Saltar al contenido
PivotalWire
Viernes 2 oct 2026SEC · NASDAQ biomédico

Calendario›BIIB›Benepali

Benepali

Benepali® PEN Patient Satisfaction Survey

Ensayo de BIOGEN INC. en Artritis reumatoide · Espondiloartropatias.

Más ensayos de: Artritis reumatoide.

Fase
no aplica
Estado
Completado
Participantes
500
previstos
Centros
38
Fin del objetivo primario
jun 2018
fecha real

Qué significa cada fase y cada estado.

Estudio observacional. Comenzó en ago 2017.

Qué mide

Porcentaje de participantes que estan "Muy satisfechos (4)" o "Satisfechos (3)" con la pluma prellenada Benepali (dia 1)

Cómo lo describe el promotor

En el documentoEn inglés, del registroThe main aim of this study is to ascertain general satisfaction among participants with rheumatic diseases with day-to-day use of the Benepali® prefilled pen by means of a standardised participant questionnaire. In addition, it is to be investigated whether differences exist in general participant satisfaction between participant groups who have undergone various prior treatment and/or have previous experience with application systems (participants new to the use of biologics, participants changing over from a prefilled injection or changing over from another pre-filled pen) and between participants of the various indication groups. Furthermore, the participants are to evaluate various aspects of using the Benepali® pre-filled pen based on their personal experience, such as e.g. handling, user-friendliness and features of the Benepali® pre-filled pen, as well as the effectiveness of the training on injection with the Benepali® pre-filled pen, based on participant satisfaction with the training received with the training pen and the evaluation of the training material received.

Más ensayos de BIIB

EnsayoFaseEstadoLectura de resultados
Diranersen · CELIAFase 2En marcha, sin reclutarmar 2026 (real)
BIIB142Fase 1Reclutando pacientesago 2026 (prevista, ya pasada: sin actualizar en el registro)
Litifilimab · TOPAZ-2Fase 3En marcha, sin reclutarsep 2026 (prevista, ya pasada: sin actualizar en el registro)
Litifilimab · TOPAZ-1Fase 3En marcha, sin reclutarsep 2026 (prevista, ya pasada: sin actualizar en el registro)
Litifilimab · AMETHYSTFase 2/3En marcha, sin reclutaroct 2026 (prevista)
Natalizumabno aplicaEn marcha, sin reclutaroct 2026 (prevista)

Todos los de BIIB, en su ficha.

Ficha completa en ClinicalTrials.gov (NCT03327454), actualizada en oct 2018.